Bleeding After Menopause: Why It Always Needs Checking

There is one symptom in menopause care that has no watch-and-wait option, and this is it.

Bleeding after menopause, which clinicians call postmenopausal bleeding, means any bleeding at all once you have gone a full twelve months without a period. A single episode counts, even if it happened only once and never came back. Spotting counts. Brown discharge counts. It does not matter that it stopped on its own.

Most women who have it do not have cancer, and every woman who has it needs to be checked. Both halves of that sentence are true, and this page explains why.

What Counts as Postmenopausal Bleeding?

The definition of menopause is stricter than most people realise. The US Office on Women’s Health puts it this way: you have reached menopause only after a full year since your last period, meaning no bleeding, including spotting, for 12 months in a row.

That detail matters twice. It means irregular bleeding during perimenopause is a different conversation, covered on our page about perimenopause symptoms. And it means the clock resets if you spot.

Once that year is complete, there is no amount of bleeding that is considered normal. Not a streak on the paper, not one episode, not something you noticed only once.

Is Bleeding After Menopause Always Cancer?

This is the question people actually type, so here is the direct answer with the numbers behind it.

A meta-analysis in JAMA Internal Medicine pooled 129 studies covering more than 40,000 women. It found the risk of endometrial cancer among women with postmenopausal bleeding was 9 percent (95 percent confidence interval 8 to 11).

The same analysis found that 91 percent of women with endometrial cancer had presented with postmenopausal bleeding. That is the reason the rule has no exceptions. The symptom is not a reliable sign of cancer, but it is the way almost all of these cancers first make themselves known.

The authors’ own conclusion is worth repeating: strategies focused on women with this symptom could capture as many as 90 percent of endometrial cancers, and most women with the symptom will not be diagnosed with one.

What Causes Bleeding After Menopause?

The causes range from entirely benign to serious, and nothing about how the bleeding looks or feels distinguishes between them:

• Thinning and fragility of the vaginal or uterine lining after estrogen falls
• Endometrial or cervical polyps, which are usually benign but can bleed
• Thickening of the uterine lining, which ranges from harmless to pre-cancerous
• Hormone therapy, particularly in the early months of a continuous regimen
• Endometrial cancer, in roughly 9 percent of cases

One caution about being told it is “just thinning”. A 2022 review argued that thinning alone does not explain the bleeding, because a small problem area such as a polyp is easy to miss when a sample is taken blindly. That is one group’s view rather than settled consensus. The practical point is simple: if the bleeding carries on after a reassuring result, go back and say so.

What Does the Assessment Involve?

Knowing what is coming makes the appointment easier to book, which is the main reason for describing it.

The scan is usually the first step, measuring how thick the lining of the womb is. It is a good triage test rather than a perfect one: pooled analysis of individual patient data put its discriminating accuracy at around 0.82 to 0.84, lower than earlier reviews had suggested. That is precisely why a sample of the lining is often taken as well.

The purpose is to rule things out quickly, and for most women that is exactly what happens. Nine times out of ten this ends with an explanation that is not cancer.

What If You Are on Hormone Therapy?

If you are on hormone therapy, the picture changes, because some bleeding is anticipated rather than abnormal. Our guide to HRT side effects and how they are managed covers the expected patterns in detail.

The distinction that matters is timing. Unpredictable spotting in the early months of a continuous regimen is common. New bleeding after months of stability is not, and it is assessed rather than watched.

The 2022 Menopause Society position statement is clear that hormone therapy should be individualised, and reviewing a bleeding pattern is part of that rather than a reason to stop treatment on your own.

Questions Women Ask Us About Postmenopausal Bleeding

Is bleeding after menopause always cancer?

No. Pooled data across 129 studies put the risk of endometrial cancer at around 9 percent, so roughly nine in ten women with this symptom have a different cause. It still needs checking, because about 91 percent of endometrial cancers first present this way.

I only spotted once and it stopped. Does that still count?

Yes. A single episode counts, and so does spotting or brown discharge. The fact that it stopped on its own does not tell you what caused it, and waiting for it to happen again removes the advantage of finding something early.

How soon should I be seen?

Promptly rather than at your next routine appointment. This is not usually an emergency department situation unless the bleeding is heavy, but it should not sit on a waiting list for months either.

What if I am on hormone therapy?

Some bleeding is expected in the first three to six months of a continuous regimen, and a monthly bleed is planned on a cyclical one. Bleeding that begins after your pattern had settled is still assessed. Do not stop the progesterone on your own, since that is what protects the lining.

Can vaginal dryness cause bleeding?

Thinning and fragility of the tissue can cause light bleeding, particularly after sex, and it is one of the more common benign explanations. It is a diagnosis made after assessment rather than assumed, because the bleeding itself looks the same either way.

What happens if the tests are normal but I keep bleeding?

Go back. Persistent bleeding after a benign result warrants another look, because focal lesions can be missed by blind sampling. Saying clearly that the bleeding has continued is the most useful thing you can do.

Medically Reviewed By

Dr. Ashar N., DNP, APRN, FNP-C, PMHNP-BC

Co-Founder & Medical Director at Tactus Health. Dual board-certified, with clinical focus on hormone therapy, medical weight loss, and aesthetics. Sugar Hill, GA and telehealth for Georgia patients.